Family Medicine

Headache Relief Shampoo Voted #1 Best New Product in 2019

headache relief shampoo bottles

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019Comments OffHeadache Drug Trial | Headache Relief | Headache Shampoo | Headache Study | Headache Therapy
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Condition:   Diarrhea-predominant Irritable Bowel Syndrome
Interventions:   Drug: BOS-589;   Drug: Placebo
Sponsor:   Boston Pharmaceuticals
Recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 6, 2019Comments OffBOS589 | Bowel | Diarrheapredominant | Efficacy | Evaluate | IBSD | Irritable | Patients | Safety | Study | Syndrome | Tolerability | Treatment
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

Conditions:   Recurrent Lung Non-Small Cell Carcinoma;   Stage IV Lung Cancer AJCC v8;   Stage IVA Lung Cancer AJCC v8;   Stage IVB Lung Cancer AJCC v8
Interventions:   Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Gemcitabine Hydrochloride;   Biological: Pembrolizumab;   Drug: Pemetrexed;   Drug: Pemetrexed Disodium;   Biological: Ramucirumab
Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019Comments OffCancer | Care | Cell | Lung | LungMAP | NonMatch | NonSmall | Patients | Pembrolizumab | Ramucirumab | Recurrent | Stage | Standard | Treating | Treatment | Trial | Versus
Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2)

Condition:   Adjunctive Treatment of Major Depressive Disorder
Interventions:   Drug: Pimavanserin;   Drug: Placebo
Sponsor:   ACADIA Pharmaceuticals Inc.
Recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 31, 2019Comments OffAdjunctive | Antidepressant | CLARITY2 | Depressive | Disorder | Efficacy | Evaluate | Inadequate | Major | Pimavanserin | Response | Safety | Study | Subjects | Treatment
Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members

Condition:   Lung Cancer
Interventions:   Behavioral: Digital-based support;   Behavioral: Traditional-based support + Nicotine replacement therapy (NRT)
Sponsor:   Indiana University
Not yet recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 30, 2019Comments OffActively | Beyond | Cancer | Clinic | Diagnosis | Family | Leveraging | Lung | Members | Oncology | Setting | Smoking
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

Condition:   Clostridium Difficile Associated Disease
Interventions:   Biological: Clostridium difficile;   Biological: Placebo
Sponsor:   Pfizer
Recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 25, 2019Comments Off2Dose | 3Dose | Clostridium | Difficile | Study | Vaccine | Versus
Prenatal Genetic Diagnosis by Genomic Sequencing

Condition:   Fetal Structural Anomalies
Intervention:   Diagnostic Test: Prenatal Genomic Sequencing
Sponsors:   Columbia University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Baylor College of Medicine;   University of North Carolina;   The George Washington University Biostatistics Center;   Oregon Health and Science University
Recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 24, 2019Comments OffDiagnosis | Genetic | Genomic | Prenatal | Sequencing
Patient and Caregiver-Centered Diabetes Telemanagement Program for Hispanic/Latino Patients

Conditions:   Type 2 Diabetes Mellitus;   Type2 Diabetes
Interventions:   Other: Comprehensive Outpatient Management;   Behavioral: Diabetes Telemonitoring
Sponsors:   Northwell Health;   Patient-Centered Outcomes Research Institute
Not yet recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 23, 2019Comments OffCaregiverCentered | Diabetes | Hispanic/Latino | Patient | Patients | Program | Telemanagement
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel TSPO Radioligand

Condition:   Dementia
Interventions:   Drug: 11C-ER176;   Drug: 11C-PIB
Sponsor:   National Institute of Mental Health (NIMH)
Not yet recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 22, 2019Comments OffDiseases | Imaging | Neurodegenerative | Neuroinflammation | Novel | Radioligand | TSPO